Vascular Solutions (VASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,934 | 2,207 | 12,734 | 8,574 | 6,003 |
| Depreciation Amortization | 2,930 | 1,453 | 4,899 | 3,615 | 2,387 |
| Income taxes - deferred | 1,573 | 638 | 1,971 | 3,050 | 458 |
| Accounts receivable | -2,908 | -1,102 | -2,741 | -1,708 | -1,332 |
| Accounts payable and accrued liabilities | 1,173 | 1,482 | 1,086 | 1,099 | 266 |
| Other Working Capital | -4,287 | -716 | -4,260 | -2,894 | -2,851 |
| Other Operating Activity | 3,877 | 938 | 3,790 | 2,518 | 2,544 |
| Operating Cash Flow | $8,292 | $4,900 | $17,479 | $14,254 | $7,475 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,010 | -5,409 | -12,776 | -3,801 | -2,292 |
| Investing Cash Flow | $-8,010 | $-5,409 | $-12,776 | $-3,801 | $-2,292 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,041 | 162 | 2,406 | 1,609 | 1,600 |
| Common Stock Repurchased | -2,276 | -1,951 | -3,131 | -2,312 | -2,290 |
| Other Financing Activity | 360 | 248 | 1,823 | 1,182 | 775 |
| Financing Cash Flow | $-875 | $-1,541 | $1,098 | $479 | $85 |
| Exchange Rate Effect | -29 | -244 | -125 | -68 | -7 |
| Beginning Cash Position | 36,461 | 36,461 | 30,785 | 30,785 | 30,785 |
| End Cash Position | 35,839 | 34,167 | 36,461 | 41,649 | 36,046 |
| Net Cash Flow | $-622 | $-2,294 | $5,676 | $10,864 | $5,261 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,292 | 4,900 | 17,479 | 14,254 | 7,475 |
| Capital Expenditure | -8,010 | -5,409 | -12,804 | -3,829 | -2,302 |
| Free Cash Flow | 282 | -509 | 4,675 | 10,425 | 5,173 |